Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
29 hedge funds and large institutions have $209M invested in Amryt Pharma plc American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 1 closing their positions.
1,400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 1
93% more funds holding
Funds holding: 15 → 29 (+14)
12% more capital invested
Capital invested by funds: $186M → $209M (+$22.4M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$15.5M |
| 2 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
+$4.2M |
| 3 |
HCM
Highbridge Capital Management
New York
|
+$2.6M |
| 4 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$2.17M |
| 5 |
TI
Telemetry Investments
New York
|
+$526K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$2K |
AMYT Hedge Fund Activity: Q1 2021 in Review
29 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q1 2021, worth a combined $209M — up 12% from $186M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new AMYT positions and 1 closed out — a net gain of 14 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $15.5M. The largest seller was Citigroup, exiting entirely with an estimated $2K sold.
- 29 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q1 2021, up from 15 in Q4 2020.
- Funds reported $209M of Amryt Pharma plc American Depositary Shares stock for Q1 2021, up 12% quarter-over-quarter.
- 15 funds opened new Amryt Pharma plc American Depositary Shares positions in Q1 2021 and 1 closed out, a net change of +14 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q1 2021 was Stonepine Capital Management, an estimated $15.5M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q1 2021 was Citigroup, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2021.